Recombinant Rat MGMT Protein，His & GST

The MGMT (O6-methylguanine-DNA methyltransferase) protein is a critical DNA repair enzyme that plays a vital role in maintaining genomic stability by removing mutagenic lesions from DNA. Specifically, it repairs O6-methylguanine, a common DNA adduct formed by exposure to alkylating agents, which can lead to mispairing during DNA replication and ultimately result in mutations or cell death. Understanding the structural and functional properties of MGMT is essential, as it has implications in cancer therapy, particularly in relation to the effectiveness of alkylating chemotherapy agents like temozolomide. In human tumors, the expression levels of MGMT can significantly influence the response to such treatments, with high levels of MGMT conferring resistance to therapy. Consequently, research into the recombinant expression of MGMT is focused on elucidating its mechanism of action, exploring its role in DNA repair pathways, and developing potential strategies to inhibit its function to enhance the efficacy of chemotherapy. By employing various recombinant protein technologies, scientists aim to generate MGMT for structural studies, enabling a clearer understanding of its enzymatic activity and interactions with DNA and small molecules. This knowledge may pave the way for innovative therapeutic approaches that could overcome MGMT-related drug resistance in cancer treatment, making it a significant focus in both basic and translational research in oncology.